OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ZDHHC2-mediated AGK palmitoylation activates AKT/mTOR signaling to reduce sunitinib sensitivity in renal cell carcinoma
Yan Sun, Liang Zhu, Pian Liu, et al.
Cancer Research (2023) Vol. 83, Iss. 12, pp. 2034-2051
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Protein lipidation in health and disease: molecular basis, physiological function and pathological implication
Yuan Yuan, Peiyuan Li, Jianghui Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 25

Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets
Edward W. Tate, Lior Soday, Ana Losada de la Lastra, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 4, pp. 240-260
Closed Access | Times Cited: 16

Cancer plasticity in therapy resistance: Mechanisms and novel strategies
Xing Niu, Wenjing Liu, Zhang Yinling, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101114-101114
Closed Access | Times Cited: 16

Protein S-palmitoylation modification: implications in tumor and tumor immune microenvironment
Yijiao Chen, Yongsheng Li, Lei Wu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9

Downregulation of UBB potentiates SP1/VEGFA-dependent angiogenesis in clear cell renal cell carcinoma
Jinpeng Wang, Enyang Zhao, Bo Geng, et al.
Oncogene (2024) Vol. 43, Iss. 18, pp. 1386-1396
Open Access | Times Cited: 6

Advances in dual-targeting inhibitors of HDAC6 for cancer treatment
Zhicheng Gu, Shuxian Lin, Junhui Yu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116571-116571
Closed Access | Times Cited: 6

ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression
Huan Zhang, Yan Sun, Zhaokai Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5

Palmitoyltransferase ZDHHC6 promotes colon tumorigenesis by targeting PPARγ-driven lipid biosynthesis via regulating lipidome metabolic reprogramming
Junqi Shan, Xinyu Li, Runqi Sun, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5

Cooperation between SIX1 and DHX9 transcriptionally regulates integrin-focal adhesion signaling mediated metastasis and sunitinib resistance in KIRC
Shiyu Huang, Juncheng Hu, Min Hu, et al.
Oncogene (2024) Vol. 43, Iss. 39, pp. 2951-2969
Closed Access | Times Cited: 5

MBD3 promotes epithelial-mesenchymal transition in gastric cancer cells by upregulating ACTG1 via the PI3K/AKT pathway
Huizhi Wang, Jingyu Min, Yuntao Ding, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 4

ZDHHC9-mediated Bip/GRP78 S-palmitoylation inhibits unfolded protein response and promotes bladder cancer progression
Weiquan Li, Jingchong Liu, Tiexi Yu, et al.
Cancer Letters (2024) Vol. 598, pp. 217118-217118
Closed Access | Times Cited: 4

Identification of immune characteristics between different subtypes in kidney renal clear cell carcinoma based on lysosome-related genes to assist immunotherapy
Yigang Jin, Qi‐Hui Zhang, Fei Wang, et al.
Human Immunology (2025) Vol. 86, Iss. 1, pp. 111223-111223
Closed Access

Unraveling the potential contribution of DHHC2 in cancer biology via untargeted metabolomics
Suchi Chaturvedi, Sibi Karthik, Sushabhan Sadhukhan, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2025), pp. 159593-159593
Closed Access

Molecular mechanisms of renal cell carcinoma metastasis and potential targets for therapy
Xinwei Li, Wei Xiong, Zhiyong Xiong, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

ZDHHC2 promoted antimycobacterial responses by selective autophagic degradation of B-RAF and C-RAF in macrophages
Junli Sheng, Xiaolong You, Dingnai Nie, et al.
Science Advances (2025) Vol. 11, Iss. 4
Open Access

Methionine Restriction Exerts Anti‐Tumor Immunity via Joint Intervention of T‐Bet Palmitoylation in Gastric Cancer
Lin Xin, Hesong Xu, Luo‐Jun Fan, et al.
Biotechnology Journal (2025) Vol. 20, Iss. 2
Closed Access

LRRK2 reduces the sensitivity to TKI and PD-1 blockade in ccRCC via activating LPCAT1
Yulong Hong, Weidong Li, Zhuo Xing, et al.
Oncogene (2025)
Closed Access

Palmitoylation in cardiovascular diseases: Molecular mechanism and therapeutic potential
Rongli Wang, Yi He, Yan Wang, et al.
IJC Heart & Vasculature (2025) Vol. 58, pp. 101675-101675
Closed Access

Molecular Mechanisms of Drug Resistance in Clear Cell Renal Cell Carcinoma
Nicoletta Bianchi, Pietro Ancona, Gianluca Aguiari
Cancers (2025) Vol. 17, Iss. 10, pp. 1613-1613
Open Access

Zdhhc1- and Zdhhc2-mediated Gpm6a palmitoylation is essential for maintenance of mammary stem cell activity
Weizhen Chen, Luyao Guo, Wei Wei, et al.
Cell Reports (2024) Vol. 43, Iss. 9, pp. 114762-114762
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top